HYPERGLIDE OCCLUSION BALLOON SYSTEM 104-4112

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,05,06 report with the FDA on 2011-11-01 for HYPERGLIDE OCCLUSION BALLOON SYSTEM 104-4112 manufactured by Ev3 Neurovascular.

Event Text Entries

[17880897] It was reported the catheter ruptured proximally to the balloon during procedure. Prior to use, the balloon was prep and confirmed work as intended. No patient injury reported.
Patient Sequence No: 1, Text Type: D, B5


[18017000] The balloon catheter has been evaluated and confirmed the catheter ruptured at approximately 9. 7 cm from the distal tip of the catheter.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2029214-2011-00360
MDR Report Key2380736
Report Source04,05,06
Date Received2011-11-01
Date of Report2011-10-11
Date of Event2011-09-20
Date Mfgr Received2011-10-03
Device Manufacturer Date2011-05-23
Date Added to Maude2012-03-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactKIM SALCEDA
Manufacturer Street9775 TOLEDO WAY
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9498373700
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHYPERGLIDE OCCLUSION BALLOON SYSTEM
Generic NameOCCLUSION BALLOON CATHETER
Product CodeNUF
Date Received2011-11-01
Model Number104-4112
Lot Number9391000
Device Expiration Date2013-08-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerEV3 NEUROVASCULAR
Manufacturer Address9775 TOLEDO WAY IRVINE CA 92618 US 92618


Patients

Patient NumberTreatmentOutcomeDate
10 2011-11-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.